Please use this identifier to cite or link to this item:
https://repositorio.bahiana.edu.br:8443/jspui/handle/bahiana/3089
Title: | A clinical score to predict mortality in septic acute kidney injury patients requiring continuous renal replacement therapy: the HELENICC score |
Other Titles: | BMC Anesthesiology |
Authors: | Passos, Rogério da Hora Ramos, João Gabriel Rosa Mendonça, Evandro Jose Bulhoes Miranda, Eva Alves Dutra, Fábio Ricardo Dantas Coelho, Maria Fernanda R. Pedroza, Andrea C. Correia, Luis Claudio L. Batista, Paulo Benigno Pena Macedo, Etienne Dutra, Margarida M. D. |
Keywords: | Septic acute kidney injury, Risk score, 7-day mortality, Hemodiafiltration |
Issue Date: | 2017 |
Abstract: | Background: This study aimed to identify predictors of early (7-day) mortality in patients with septic acute kidney injury (AKI) who required continuous renal replacement therapy (CRRT). Methods: Prospective cohort of 186 septic AKI patients undergoing CRRT at a tertiary hospital, from October 2005 to November 2010. Results: After multivariate adjustment, five variables were associated to early mortality: norepinephrine utilization, liver failure, medical condition, lactate level, and pre-dialysis creatinine level. These variables were combined in a score, which demonstrated good discrimination, with a C-statistic of 0.82 (95% CI = 0.76–0.88), and good calibration (χ 2 = 4.3; p = 0.83). SAPS 3, APACHE II and SOFA scores demonstrated poor performance in this population. Conclusions: The HEpatic failure, LactatE, NorepInephrine, medical Condition, and Creatinine (HELENICC) score outperformed tested generic models. Future studies should further validate this score in different cohorts. |
URI: | http://www7.bahiana.edu.br//jspui/handle/bahiana/3089 |
ISSN: | 1471-2253 |
Appears in Collections: | Artigos Completos Publicados em Periódicos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ARTIGO - ROGERIO DA HORA PASSOS - 2017.1.pdf | 488,19 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.